Nephrology, Dialysis, Transplantation

Sex in CKD trials: representation and treatment effects of cardiorenoprotective therapies

By Ioannis Bellos, Μαρία Αθανασίου, Konstantina S. Nikita, Vassiliki Benetou

ReviewPopulations

The paper

Ioannis Bellos, Μαρία Αθανασίου, Konstantina S. Nikita, Vassiliki Benetou

National and Kapodistrian University of Athens

Nephrology, Dialysis, Transplantation, 31 Aug 2026

doi.org/10.1093/ndt/gfag199 PubMed 42671242

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance